CAPR 18.92 (+2.49%)
US14070B3096BiotechnologyBiotechnology

Capricor Therapeutics (CAPR) Financial Metrics

This table shows a selected set of financial data points of Capricor Therapeutics (CAPR). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2023 -0.83 0 -5.88 130.95M -0.41 25.18M -27.64M -24.73M -22.29M 14.69M
2022 -1.18 0 -3.27 94.77M -0.63 2.55M 1.56M -29.65M -29.02M 9.6M
2021 -0.87 0 -3.38 67.65M -0.53 244.9K -18.01M -21.06M -20.02M 34.89M
2020 -0.88 0 -3.91 53.41M -0.6 310.25K -10.6M -13.58M -13.66M 32.67M
2019 -2.06 0 -0.62 4.75M -0.75 1.01M -6.82M -7.83M -7.64M 3.9M
2018 -5.17 0 -0.79 12.06M -1.19 1.67M -14.18M -15.03M -15.19M 4.26M
2017 0.91 0 17.41 42.33M 0.14 2.67M -14.26M 2.97M 2.43M 6.14M
2016 -10.14 0 -2.62 49.35M -1.08 4M -16M -18.34M -18.81M 3.2M
2015 -8.09 0 -3.8 48.82M -0.87 5.52M -10.97M -12.5M -12.86M 5.57M
2014 -5.31 0 -7.06 43.86M -0.65 4.79M 772.13K -5.97M -6.22M 8.03M
2013 -8.47 0 -3.84 34.13M -3.08 503.23K -6.25M -8.81M -8.89M 1.73M
2012 -22.43 0 -1.11 2.11M -2.37 195.5K -2.19M -1.89M -1.89M 46.72K
2011 -65.43 0 -4.2 20.53M -1.94 1.35M -4.65M -4.88M -4.88M 1.04M
2010 -93.75 0 -3.31 19.94M -1.66 0 -4.32M -6.02M -6.03M 3.38M
2009 -154.56 0 -3.91 30.81M -1.57 0 -5.83M -7.71M -7.87M 3.18M
2008 -272.15 0 -1.56 20.51M -1.12 0 -10.73M -13.02M -13.13M 5.5M
2007 -304.06 0 -9.04 93.18M -1.21 101.4K -5.66M -9.19M -10.3M 16.23M
2006 -40.63 0 0 0 -436.68 0 -55.6K -60.4K -61.35K 0
2005 -12.49 0 0 0 -41.18 0 -17.79K -18.86K -18.86K 281
2004 -11.97 0 0 0 -21.09 0 -15.48K -18.08K -18.08K 635
2003 -10.7 0 0 0 -29.27 2.18K -20.82K -16.16K -16.16K 1.08K
2002 -10.32 0 0 0 -116.32 11.48K -14.32K -15.59K -15.59K 25
2001 -14.77 0 0 0 -3.08 0 -13.02K -22.22K -22.3K 156
2000 -26.56 0 0 0 -5.02 0 -37.32K -36.32K -36.52K 13.18K
1999 -0.2 0 0 0 0 0 0 0 -200 0

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.